![]() | GLENN W CurrierShow email addressDepartment of Psychiatry and Behavioral Neurosciences, University of South Florida, Tampa, Florida, USA. | Rashid Laboratory for Developmental Neurobiology, Silver Child ... |
Is this your profile? Claim your profile Copy URL Embed Link to your profile |
GLENN W Currier:Expert Impact
Concepts for whichGLENN W Currierhas direct influence:Emergency department,Behavioral emergencies,Psychotic agitation,Suicidal patients,Acute agitation,Suicide risk,Sexual orientation,Military service.
GLENN W Currier:KOL impact
Concepts related to the work of other authors for whichfor which GLENN W Currier has influence:Suicidal ideation,Suicide risk,Mental health,Bipolar disorder,Emergency department,Acute agitation,Depressive symptoms.
KOL Resume for GLENN W Currier
Year | |
---|---|
2021 | Department of Psychiatry and Behavioral Neurosciences, University of South Florida, Tampa, Florida, USA. |
2019 | Department of Psychiatry & Behavioral Neurosciences, Morsani College of Medicine, University of South Florida, Tampa, Florida |
2018 | Department of Psychiatry & Behavioral Neurosciences, Morsani College of Medicine, University of South Florida, Tampa, FL, USA |
2017 | Department of Psychiatry and Behavioral Neurosciences, Rashid Laboratory for Developmental Neurobiology, Silver Child Development Center, Morsani College of Medicine, University of South Florida, Tampa, FL, USA |
2016 | Department of Psychiatry and Behavioral Neurosciences, Morsani College of Medicine, University of South Florida, Tampa, FL |
2015 | University of Rochester Medical Center, Department of Emergency Medicine, Rochester, New York |
2014 | VA Center of Excellence, Canandaigua, NY, United States |
2013 | University of Rochester Medical Center, Rochester, NY. |
2012 | University of Rochester Medical Center, Departments of Psychiatry and Emergency Medicine, Rochester, New York |
2011 | From the Department of Psychiatry and the Division of Child and Adolescent Psychiatry, Columbia University, College of Physicians and Surgeons, and New York State Psychiatric Institute, New York; Department of Psychiatry, University of Pennsylvania, Philadelphia; University of Pittsburgh School of Medicine and Western Psychiatric Institute and Clinic, Pittsburgh; Department of Psychiatry, University of Rochester Medical Center, Rochester, N.Y.; and the Monash University Centre for Developmental Psychiatry and Psychology, Victoria, Australia. School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, New York, USA. |
2010 | VISN 2 Center of Excellence for Suicide Prevention, U.S. Veterans Administration, and affiliated with the University of Rochester Medical Center in Rochester, NY |
2009 | From the Center for Public Health and Population Interventions for Preventing Suicide, Department of Psychiatry, University of Rochester Medical Center (GWC, EDC), Rochester, NY; the Department of Emergency Medicine, University of Rochester Medical Center (GWC), Rochester, NY; and the Department of Community & Preventive Medicine, University of Rochester Medical Center (SGF), Rochester, NY |
2008 | Departments of Psychiatry and Emergency Medicine at the University of Rochester in New York. Department of Psychiatry, University of Rochester, NY |
2007 | DANIEL: United BioSource Corporation, McLean, VA; CURRIER: University of Rochester Medical Center, Rochester, NY; ZIMBROFF: Pacific Clinical Research Medical Group, Upland, CA; ALLEN: University of Colorado School of Medicine, Denver, CO; OREN and MANOS: Bristol-Myers Squibb Company, Wallingford, CT; MCQUADE: Otsuka America Pharmaceutical, Inc. Princeton, NJ; PIKALOV: Otsuka America Pharmaceutical, Inc., Rockville, MD; CRANDALL: Bristol-Myers Squibb Company, Plainsboro, NJ. |
2006 | From the American College of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on Critical Issues in the Diagnosis and Management of the Adult Psychiatric Patient in the Emergency Department VESER, VESER, and ZEALBERG: Medical University of South Carolina, Charleston; MCMULLAN: University of Cincinnati; CURRIER: University of Rochester, NY. CEREL: University of Kentucky, College of Social Work; CURRIER and CONWELL: University of Rochester School of Medicine and Dentistry. CURRIER: University of Rochester Medical Center, Rochester, New York; MEDORI: Janssen-Cilag EMEA, Beerse, Belgium. |
2005 | Department of Psychiatry and Emergency Medicine, University of Rochester School of Medicine, Rochester, New York, USA University of Colorado School of Medicine (Allen) University of Rochester School of Medicine (Currier) Comprehensive NeuroScience, Inc. (Carpenter) Ross Editorial (Ross) Comprehensive NeuroScience, Inc. (Docherty) |
2004 | Departments of Psychiatry and Emergency Medicine, University of Rochester Medical Center, 300 Crittenden Boulevard, Rochester, N.Y. 14642, USA. Department of Emergency Medicine, University of Rochester Medical Center, Rochester, New York University of Rochester Medical Center, Rochester, NY, USA |
2003 | University of Rochester School of Medicine, NY 14642, USA. |
2002 | Department of Psychiatry, University of Rochester School of Medicine, 300 Crittenden Boulevard, 14642, Rochester, New York, USA |
2001 | Department of Psychiatry, University of Rochester, NY 14642, USA. |
2000 | Departments of Psychiatry and Emergency Medicine, University of Rochester School of Medicine, Rochester, New York. Send reprint requests to Dr. Currier, URMC Department of Psychiatry, 300 Crittenden Boulevard, Rochester, New York 14534. University of Rochester School of Medicine, NY, USA. |
1999 | Glenn W. Currier, M.D., M.P.H., is director of emergency psychiatry at Los Angeles County—University of Southern California Medical Center and assistant professor of psychiatry at the USC School of Medicine |
1995 | Psychiatry at Bellevue Hospital, New York University Medical Center |
Concept | World rank |
---|---|
authors feifel | #1 |
combination emergency services | #1 |
risperidone lorazepam | #1 |
variety benzodiazepines | #1 |
medical condition clinicians | #1 |
involuntary medications | #1 |
sgas preferred | #1 |
patientfocused intensive | #1 |
bnzs data | #1 |
bnzs recommended | #1 |
psychosis emergency | #1 |
treatment moderate agitation | #1 |
experts interventions | #1 |
sites medical clearance | #1 |
prioritize finances | #1 |
psychopharmacology agitation | #1 |
82 services | #1 |
project beta | #1 |
strategies key | #1 |
olanzapine bnz | #1 |
benzodiazepines rated | #1 |
bnzs situations | #1 |
corporation 9 | #1 |
families attempted surveys | #1 |
scores bars | #1 |
agitation variety | #1 |
extraordinary practices | #1 |
50 experts elements | #1 |
consequences future psychiatric | #1 |
gaps psychotic | #1 |
beta psychopharmacology | #1 |
situations oral olanzapine | #1 |
emergency clinical factors | #1 |
real patients safeguards | #1 |
consensus option | #1 |
preferred agitation | #1 |
management psychotic presentations | #1 |
ratings risperidone | #1 |
emergencies behaviors | #1 |
Sign-in to see all concepts, it's free! | |
Prominent publications by GLENN W Currier
Comparison of the Safety Planning Intervention With Follow-up vs Usual Care of Suicidal Patients Treated in the Emergency Department
[ PUBLICATION ]
Importance: Suicidal behavior is a major public health problem in the United States. The suicide rate has steadily increased over the past 2 decades; middle-aged men and military veterans are at particularly high risk. There is a dearth of empirically supported brief intervention strategies to address this problem in health care settings generally and particularly in emergency departments (EDs), where many suicidal patients present for care.
Objective: To determine whether the Safety ...
Known for Suicidal Patients | Emergency Department | Safety Planning Intervention | United States | 6 Months |
OBJECTIVES: Due to inherent dangers and barriers to research in emergency settings, few data are available to guide clinicians about how best to manage behavioral emergencies. Key constructs such as agitation are poorly defined. This lack of empirical data led us to undertake a survey of expert opinion, results of which were published in the 2001 Expert Consensus Guidelines on the Treatment of Behavioral Emergencies. Several second-generation (atypical) antipsychotics (SGAs) are now ...
Known for Olanzapine Ziprasidone | Treatment Agitation | Oral Risperidone | Emergency Medical | Expert Consensus |
OBJECTIVE: Research on suicide prevention and interventions requires a standard method for assessing both suicidal ideation and behavior to identify those at risk and to track treatment response. The Columbia-Suicide Severity Rating Scale (C-SSRS) was designed to quantify the severity of suicidal ideation and behavior. The authors examined the psychometric properties of the scale.
METHOD: The C-SSRS's validity relative to other measures of suicidal ideation and behavior and the internal ...
Known for Suicide Severity | Rating Scale | Initial Validity | Suicidal Ideation Behavior | Study Adults |
OBJECTIVE: To evaluate response to intramuscular (IM) aripiprazole injections using secondary analyses from clinical trials.
METHODS: Data from one trial in patients with bipolar I disorder and two trials in patients with schizophrenia were assembled and used for three secondary analyses. Analysis 1 looked at data from "nonsedated" patients (i.e., patients with scores < 8 [deep sleep] or 9 [unarousable] on the Agitation-Calmness Evaluation Scale [ACES]). In analysis 2, patients were ...
Known for Intramuscular Aripiprazole | Bipolar Disorder | Agitation Patients | Pec Scores | Topic Schizophrenia |
Assessing the Competence of Persons With Alzheimers Disease in Providing Informed Consent for Participation in Research
[ PUBLICATION ]
OBJECTIVE: The capacity of persons with Alzheimer's disease or other neuropsychiatric disorders for giving consent to participate in research has come under increasing scrutiny. While instruments for measuring abilities related to capacity have been developed, how they should be used to categorize subjects as capable or incapable is not clear. A criterion validation study was carried out to help address this question.
METHOD: The authors measured the ability of 37 subjects with ...
Known for Alzheimers Disease | Informed Consent | Capacity Persons | Normative Values | Comparison Subjects |
OBJECTIVE: To report efficacy and safety of transitioning patients receiving intramuscular (IM) formulations of aripiprazole or haloperidol to their respective oral formulations.
METHODS: 448 agitated patients with schizophrenia (73%) or schizoaffective disorder (27%) were randomized to receive aripiprazole IM 9.75 mg, haloperidol IM 6.5 mg, or placebo IM within 24 hours. Patients treated with aripiprazole IM or haloperidol IM who completed this 24-hour IM phase were transitioned to the ...
Known for Oral Aripiprazole | Acute Treatment | Schizoaffective Disorder | Patients Schizophrenia | 10 Day |
OBJECTIVE: To compare oral risperidone and intramuscular (IM) haloperidol, both in combination with IM lorazepam, in the management of acute agitation and psychosis in the medical emergency department.
METHODS: In this prospective, randomized, placebo-controlled, double-blind study of 30 patients presenting to the emergency department with acute agitation and/or psychosis, three groups of 10 patients received oral and IM medications: 1) 2 mg oral risperidone and 2 mg IM lorazepam; 2) 5 ...
Known for Acute Agitation | Haloperidol Lorazepam | Emergency Department | Oral Medications | 10 Patients |
There are no evidence-based, brief interventions to reduce suicide risk in Veterans. Death by suicide is a major public health problem. This article describes a protocol, Suicide Assessment and Follow-up Engagement: Veteran Emergency Treatment [SAFE VET], developed for testing the effectiveness of a brief intervention combining a Safety Planning Intervention with structured follow-up (SPI-SFU) to reduce near-term suicide risk and increase outpatient behavioral health treatment engagement ...
Known for Emergency Department | Safety Planning | Risk Suicide | Study Protocol | Veterans Affairs Veterans |
NIH Roundtable on Opportunities to Advance Research on Neurologic and Psychiatric Emergencies
[ PUBLICATION ]
STUDY OBJECTIVE: The Institute of Medicine Committee on the Future of Emergency Care in the United States Health System (2003) identified a need to enhance the research base for emergency care. As a result, a National Institutes of Health (NIH) Task Force on Research in Emergency Medicine was formed to enhance NIH support for emergency care research. Members of the NIH Task Force and academic leaders in emergency care participated in 3 Roundtable discussions to prioritize current ...
Known for Emergency Medicine | Psychiatric Emergencies | Health Nih | Task Force | National Institutes |
OBJECTIVES: Many suicidal patients treated and released from emergency departments (ED) fail to follow through with subsequent outpatient psychiatric appointments, often presenting back for repeat ED services. Thus, the authors sought to determine whether a mobile crisis team (MCT) intervention would be more effective than standard referral to a hospital-based clinic as a means of establishing near-term clinical contact after ED discharge. This objective was based on the premise that ...
Known for Mobile Crisis | Emergency Department | Controlled Trial | Suicidal Patients | Mental Health |
Psychiatric emergency services (PES) are evolving as freestanding, parallel components of emergency departments at many tertiary care medical centers in the U.S. While PES facilities provide an increasing percentage of first-line care for patients with psychiatric crises, the services they provide and their interactions with medical emergency services have not been systematically assessed. The purpose of this study was to examine PES structure, care processes, patient characteristics and ...
Known for Emergency Services | Academic Psychiatric | Pes Facilities | Substance Abuse | Medical Centers |
Consumer and Family Experiences in the Emergency Department Following a Suicide Attempt
[ PUBLICATION ]
OBJECTIVE: To understand the separate experiences of consumers (patients) and family members in the Emergency Department (ED) following a suicide attempt.
METHODS: Separate anonymous surveys were created for two groups: 1) consumers (n = 465) who had made a suicide attempt and been to the ED, and 2) others (referred to here as family members; n = 254) who had a close friend or relative treated in an ED due to suicidal behavior. Surveys were available on the National Alliance on Mental ...
Known for Suicide Attempt | Emergency Department | Negative Experiences | Suicidal Behavior | Health Personnel |